Brighthouse SmartCare
SmartCare is the hybrid long-term care policy for buyers who want cash benefits and are willing to accept a more complex life-insurance chassis to get them. The Drew-and-Darrick case for it is simple: cash indemnity, strong value, flexible premium schedules, and Brighthouse's long insurance lineage. The trade-off is just as real: a 90-day waiting period and more moving parts than a simpler fixed hybrid.
Watch the SmartCare Review
Drew Nichols and Darrick Wilkins break down why SmartCare keeps showing up in hybrid LTC conversations: cash indemnity, good value, international-planning appeal, and better-than-expected funding flexibility. I also updated the page with current public Brighthouse materials so it does not stop at the transcript.
Why SmartCare Keeps Making the Shortlist
The core SmartCare pitch is not subtle: get cash-style LTC benefits, keep a life-insurance backstop if care is never needed, and add growth potential on top. That combination is why this product gets quoted even by advisors who are not generally IUL enthusiasts.
Cash indemnity, not reimbursement
The current public SmartCare brochure describes monthly LTC benefits paid as cash indemnity. Once a claim is approved, the benefit is meant to be spendable without a receipt chase, which is exactly why this product gets attention from families expecting informal caregivers or uneven home-care costs.
Indexed life chassis with upside
SmartCare is not a plain fixed hybrid. It sits on indexed universal life, so the death benefit, cash value, and some LTC growth options can participate in index-linked upside while still keeping a floor against market loss on the indexed side.
More design flexibility than the video showed
The current public brochure shows indexed, level, 3% compound, and 5% compound LTC growth choices. Funding is also broader than the old single-pay or 5-pay framing: the current brochure shows single premium, annual pay for 2 to 5 years, and a 10-year option on eligible versions.
Still relevant for global retirement planning
Drew and Darrick highlight SmartCare as a meaningful option for clients who may spend retirement abroad. That is still one of the reasons we keep it in the conversation, but foreign-care language is always something to confirm in the specimen policy before making it the deciding factor.
Date cleanup from the video: the transcript calls Brighthouse a MetLife spin-off from 2016. The fuller official timeline is that MetLife announced the separation in January 2016, and Brighthouse completed the separation and began trading independently in August 2017.
What You Are Actually Buying
SmartCare is an indexed universal life policy with long-term care riders, not a traditional stand-alone LTC contract. That matters because the policy can be shaped several ways: indexed LTC growth, fixed 3% or 5% compound growth, or level LTC amounts. It also means policy charges and illustration assumptions matter more than they do on a simpler fixed hybrid.
The current public brochure also shows the claim structure more clearly than the video transcript does. The long-term care acceleration rider handles the first two years of a claim, and the extension rider can continue benefits for two or four more years. In plain English, the public client brochure usually points you toward a 4-year or 6-year total LTC payout design.
That makes SmartCare less of a pure life-insurance play and more of a structured LTC pool with life-insurance features attached. For the right buyer, that is a strength, not a bug. But you do want the illustration explained line by line.
Two Brighthouse Links Worth Reading
If you want to verify this page yourself, these are the two public Brighthouse documents I would read first. They cover the current design better than the video alone.
Current client brochure
Best public source for the actual mechanics: cash indemnity claim language, 3% or 5% compound options, 2-to-5-pay plus 10-pay availability, return-of-premium riders, and the 90-day elimination period.
Read the brochureJuly 22, 2024 enhancement release
This is the clean official source for the newer 3% compound option and the added return-of-premium surrender and death-benefit riders that did not exist in the original 2019 launch version.
Read the 2024 updateThe Trade-Offs Are Real
SmartCare deserves a quote, but it should rarely be bought in isolation. The product asks you to accept some complexity in exchange for cash benefits and upside potential.
90-day elimination period
The current brochure says benefit payments begin after 90 calendar days once eligibility requirements are met. That is normal for many hybrids, but it is a real disadvantage next to Lincoln's zero-day design.
More moving parts than a simpler hybrid
Because SmartCare is indexed universal life, you need to understand charges, cap-rate style mechanics, and how illustrated growth differs from guaranteed values. If you want the cleanest possible explanation, Securian and Nationwide are usually easier to explain.
LTC use reduces the life side
The brochure is explicit that benefits paid from the LTC acceleration rider reduce the death benefit dollar for dollar and reduce other policy values proportionately. That is not unique to SmartCare, but it matters when buyers assume the life insurance stays untouched.
10-pay is not universal across every design
Brighthouse's current public brochure says the 10-year premium payment option is available on the fixed-growth and level versions at this time. That means you still have to look at the exact design being illustrated, not just the brand name.
Our bias here: if you like the SmartCare story, quote it against Securian, Nationwide, and often Lincoln. SmartCare often wins when the buyer values cash benefits and growth potential in one chassis. It loses when the buyer wants maximum simplicity or day-one home-care benefits.
SmartCare vs. a Typical Hybrid Peer
The reason SmartCare is interesting is that it is not just another death-benefit-plus-LTC policy. The indexed life chassis changes the comparison.
| Feature | Brighthouse SmartCare | Typical hybrid peer |
|---|---|---|
| Claim model | 100% cash indemnity | Varies, cash or reimbursement |
| Life insurance chassis | Indexed universal life | Whole life, UL, IUL, or mixed |
| LTC growth choices | Indexed, level, 3% compound, or 5% compound | Varies by carrier |
| Typical total benefit duration | Commonly 4 or 6 years total | Varies by design |
| Funding choices | Single pay, 2 to 5 pay, or 10 pay on eligible versions | Varies by carrier |
| Elimination period | 90 calendar days | Often 90 days |
| Core sales appeal | Cash benefits plus growth potential | Usually either simplicity or leverage, not both |
How SmartCare's Indexed Inflation Actually Works
This is the part of SmartCare most people misunderstand. The indexed option is not the same as a guaranteed 3% compound rider. It is cheaper up front because the future LTC growth is market-linked, not locked in. That can be better than 3% in a strong year and worse in a flat one.
What the indexed option is
LTC Tree calls this 'indexed inflation protection.' Brighthouse's current client materials call it the Indexed LTC option. Instead of a fixed annual compound increase, the policy can credit growth based on selected market indices up to an annual cap, with a 0% floor on the indexed account.
Why the first-year example mattered
In the policy anniversary example from the video, the client's monthly LTC benefit moved from about $6,697 to $7,160 in year one. Darrick compares that to roughly $6,899 under a plain 3% compound design, which is the upside case SmartCare buyers are hoping for.
Why it is not a free lunch
The growth is not guaranteed. Cap rates can change, index credits are limited, and internal policy charges still have to be paid. That is why the client's actual LTC increase was well below the raw market return Darrick and Drew discuss in the video.
The current Brighthouse brochure now shows four LTC growth paths: indexed, level, 3% compound, and 5% compound. That means the video is best understood as an explanation of the indexed path specifically, not the entire SmartCare menu as it exists today.
Brighthouse's public historical-rates flyer says indexed LTC growth is credited up to an annual cap, and that prior cap rates are not a guarantee of future rates. The current renewal sheets also explain that indexed accounts credit the lower of the cap rate or index performance, with a 0% floor when the chosen index has a negative year. In plain language: you have upside, but it is throttled, and weak years can mean no growth.
The LTC Tree video also makes an important practical point: the buyer does not need a decade of heroic returns for the indexed option to matter. If a policy banks strong crediting in the first few years, the starting LTC benefit can pull ahead of a plain 3% compound design early. That is the case for SmartCare when it wins.
The honest takeaway: if you want predictable inflation growth, use the fixed 3% or 5% SmartCare options or compare a carrier with standard compound inflation. If you are willing to accept non-guaranteed growth for a lower upfront cost and a shot at better early performance, the indexed option is the reason Brighthouse belongs in the spreadsheet.
Who SmartCare Fits Best
When to Compare Elsewhere
See SmartCare Next to the Other Real Options
We're LTC Tree, independent, and happy to compare Brighthouse side-by-side with Securian, Nationwide, Lincoln, OneAmerica, and the rest. That is the only honest way to buy a hybrid policy, because SmartCare wins for some buyers and clearly loses for others.
Or call 1-800-800-6139